Literature DB >> 33495437

Tumor exosome promotes Th17 cell differentiation by transmitting the lncRNA CRNDE-h in colorectal cancer.

Junfeng Sun1, Haowei Jia1, Xingqi Bao1, Yue Wu1, Tianyu Zhu1, Ruixin Li1, Hongchao Zhao2.   

Abstract

The T helper 17 (Th17) cells in tumor microenvironment play an important role in colorectal cancer (CRC) progression. This study investigated the mechanism of Th17 cell differentiation in CRC with a focus on the role of tumor exosome-transmitted long noncoding RNA (lncRNA). Exosomes were isolated from the CRC cells and serum of CRC patients. The role and mechanism of the lncRNA CRNDE-h transmitted by CRC exosomes in Th17 cell differentiation were assessed by using various molecular biological methods. The serum exosomal CRNDE-h level was positively correlated with the proportion of Th17 cells in the tumor-infiltrating T cells in CRC patients. CRC exosomes contained abundant CRNDE-h and transmitted them to CD4+ T cells to increase the Th17 cell proportion, RORγt expression, and IL-17 promoter activity. The underlying mechanism is that, CRNDE-h bound to the PPXY motif of RORγt and impeded the ubiquitination and degradation of RORγt by inhibiting its binding with the E3 ubiquitin ligase Itch. The in vivo experiments confirmed that the targeted silence of CRNDE-h in CD4+ T cells attenuated the CRC tumor growth in mice. The present findings demonstrated that the tumor exosome transmitted CRNDE-h promoted Th17 cell differentiation by inhibiting the Itch-mediated ubiquitination and degradation of RORγt in CRC, expanding our understanding of Th17 cell differentiation in CRC.

Entities:  

Year:  2021        PMID: 33495437      PMCID: PMC7835218          DOI: 10.1038/s41419-020-03376-y

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  40 in total

1.  Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination.

Authors:  Mahesh Kathania; Prashant Khare; Minghui Zeng; Brandi Cantarel; Haiying Zhang; Hideki Ueno; K Venuprasad
Journal:  Nat Immunol       Date:  2016-06-20       Impact factor: 25.606

2.  Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.

Authors:  Marie Tosolini; Amos Kirilovsky; Bernhard Mlecnik; Tessa Fredriksen; Stéphanie Mauger; Gabriela Bindea; Anne Berger; Patrick Bruneval; Wolf-Herman Fridman; Franck Pagès; Jérôme Galon
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

3.  LncRNA CRNDE affects the proliferation and apoptosis of vascular smooth muscle cells in abdominal aortic aneurysms by regulating the expression of Smad3 by Bcl-3.

Authors:  Kun Li; Mingzhe Cui; Kewei Zhang; Guoquan Wang; Shuiting Zhai
Journal:  Cell Cycle       Date:  2020-04-02       Impact factor: 4.534

4.  The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.

Authors:  Peng Han; Jing-Wen Li; Bo-Miao Zhang; Jia-Chen Lv; Yong-Min Li; Xin-Yue Gu; Zhi-Wei Yu; Yun-He Jia; Xue-Feng Bai; Li Li; Yan-Long Liu; Bin-Bin Cui
Journal:  Mol Cancer       Date:  2017-01-13       Impact factor: 27.401

5.  Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer.

Authors:  Hongyan Gao; Xiaodi Song; Ting Kang; Baohong Yan; Li Feng; Li Gao; Liang Ai; Xiaoni Liu; Jie Yu; Huiqi Li
Journal:  Onco Targets Ther       Date:  2017-01-05       Impact factor: 4.147

6.  Diagnostic potential of serum exosomal colorectal neoplasia differentially expressed long non-coding RNA (CRNDE-p) and microRNA-217 expression in colorectal carcinoma.

Authors:  Bo Yu; Qiong Du; Huan Li; Hong-Yue Liu; Xuan Ye; Bin Zhu; Qing Zhai; Xin-Xiang Li
Journal:  Oncotarget       Date:  2017-07-20

Review 7.  Exosomes as carriers transporting long non‑coding RNAs: Molecular characteristics and their function in cancer (Review).

Authors:  Damian Kołat; Raneem Hammouz; Andrzej K Bednarek; Elżbieta Płuciennik
Journal:  Mol Med Rep       Date:  2019-06-05       Impact factor: 2.952

8.  LncRNA H19 over-expression inhibited Th17 cell differentiation to relieve endometriosis through miR-342-3p/IER3 pathway.

Authors:  Zheying Liu; Liya Liu; Yun Zhong; Mingbo Cai; Junbi Gao; Chaoyue Tan; Xiaoxiao Han; Ruixia Guo; Liping Han
Journal:  Cell Biosci       Date:  2019-10-15       Impact factor: 7.133

Review 9.  TH9, TH17, and TH22 Cell Subsets and Their Main Cytokine Products in the Pathogenesis of Colorectal Cancer.

Authors:  Guanglin Cui
Journal:  Front Oncol       Date:  2019-10-04       Impact factor: 6.244

10.  Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.

Authors:  David R Withers; Matthew R Hepworth; Xinxin Wang; Emma C Mackley; Emily E Halford; Emma E Dutton; Clare L Marriott; Verena Brucklacher-Waldert; Marc Veldhoen; Judith Kelsen; Robert N Baldassano; Gregory F Sonnenberg
Journal:  Nat Med       Date:  2016-02-15       Impact factor: 53.440

View more
  14 in total

1.  AK4P1 is a cancer-promoting pseudogene in pancreatic adenocarcinoma cells whose transcripts can be transmitted by exosomes.

Authors:  Ling Li; Tao Deng; Qiuying Zhang; Yanlong Yang; Yang Liu; Leyong Yuan; Mingshui Xie
Journal:  Oncol Lett       Date:  2022-03-28       Impact factor: 2.967

Review 2.  RORγt protein modifications and IL-17-mediated inflammation.

Authors:  Ritesh Kumar; Arianne L Theiss; K Venuprasad
Journal:  Trends Immunol       Date:  2021-10-09       Impact factor: 16.687

Review 3.  Small Extracellular Vesicles: Key Forces Mediating the Development and Metastasis of Colorectal Cancer.

Authors:  Wenjie Zhang; Xiaoxue Hu; Zhengting Jiang
Journal:  Cells       Date:  2022-05-29       Impact factor: 7.666

Review 4.  Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers.

Authors:  Zimo Jia; Jinlin Jia; Lihui Yao; Zhihan Li
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

5.  Long non-coding RNA AC087388.1 as a novel biomarker in colorectal cancer.

Authors:  Arash Poursheikhani; Mohammad Reza Abbaszadegan; Mohammad Amin Kerachian
Journal:  BMC Cancer       Date:  2022-02-21       Impact factor: 4.430

Review 6.  Potential Roles of Exosomal lncRNAs in the Intestinal Mucosal Immune Barrier.

Authors:  Shanshan Chen; Ruonan He; Beihui He; Li Xu; Shuo Zhang
Journal:  J Immunol Res       Date:  2021-08-25       Impact factor: 4.818

Review 7.  CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies.

Authors:  Xuefei Ma; Wen Jin; Chaoxian Zhao; Xuefeng Wang; Kankan Wang
Journal:  Mol Ther Nucleic Acids       Date:  2022-03-09       Impact factor: 8.886

8.  Exosome to Promote Cancer Progression via Its Bioactive Cargoes.

Authors:  Austin McMasters; Kelly M McMasters; Hongying Hao
Journal:  Arch Cancer Biol Ther       Date:  2021-06

Review 9.  Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma.

Authors:  Jieyu He; Lin Ling; Zhongyue Liu; Xiaolei Ren; Lu Wan; Chao Tu; Zhihong Li
Journal:  Cancer Cell Int       Date:  2021-06-15       Impact factor: 5.722

Review 10.  Oncogenic Role of Exosomal Circular and Long Noncoding RNAs in Gastrointestinal Cancers.

Authors:  Ba Da Yun; Ye Ji Choi; Seung Wan Son; Gabriel Adelman Cipolla; Fernanda Costa Brandão Berti; Danielle Malheiros; Tae-Jin Oh; Hyo Jeong Kuh; Soo Young Choi; Jong Kook Park
Journal:  Int J Mol Sci       Date:  2022-01-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.